ACU Q2 2026 Earnings: EPS Beats Estimates as MyMedic Acquisition Drives Growth

• Acme United Corporation (ACU) reported Q2 2026 EPS of $1.22, significantly surpassing analyst estimates of $0.81.
• Revenue reached $62.7 million, beating forecasts of $58.1 million, driven by a 16% year-over-year sales increase.
• The acquisition of MyMedic was a primary catalyst for growth, contributing to an 8% organic sales increase.
• Gross margins expanded to 42.6% from 41.0% in the prior year, signaling improved operational efficiency.

Acme United Corporation (ACU) delivered a robust financial performance for the second quarter of 2026, significantly exceeding market expectations. The company reported earnings per share (EPS) of $1.22, a substantial beat against the consensus forecast of $0.81 . This 50.62% surprise reflects strong operational execution and the successful integration of recent strategic acquisitions . Revenue also surpassed estimates, coming in at $62.7 million compared to the projected $58.1 million . The stock market reacted positively to these results, with shares surging approximately 11.92% and moving near a 52-week high of $51.88 . This price action underscores investor confidence in the company's growth trajectory and profitability improvements.

The primary driver behind this outperformance was the integration of the MyMedic acquisition. This strategic move contributed to a 16% year-over-year increase in total sales . However, when excluding the impact of acquisitions, organic sales grew by 8%, indicating healthy underlying business momentum . Management highlighted that this combination of inorganic and organic growth has been instrumental in expanding profitability metrics. The company’s ability to leverage acquisitions while maintaining steady organic growth demonstrates a balanced approach to capital allocation and expansion .

How Did Gross Margins Expand?

Gross margins for the second quarter expanded to 42.6%, up from 41.0% in the prior year period . This improvement highlights the company's enhanced operational efficiency and pricing power. CEO Johnsen indicated that this margin recovery is expected to continue as the company transitions its inventory mix . Specifically, lower-cost stock is gradually replacing higher-tariff inventory, which alleviates pressure on costs through the end of the year . The company also noted that tariff and freight costs are anticipated to ease, providing further tailwinds for profitability .

This strategic inventory management is crucial for maintaining margins in a volatile trade environment. By proactively adjusting to tariff changes, Acme United has mitigated some of the external pressures that typically impact gross margins . The focus on transitioning to lower-cost stock suggests a proactive approach to cost control, which is likely to support future financial performance .

What Are the Key Risks for Investors?

Despite the positive results, several risks warrant attention. Selling, general, and administrative (SG&A) expenses remain elevated at 32% of sales . This high expense ratio could pressure net income if not managed effectively. Additionally, the company faces ongoing challenges from potential tariff and freight cost volatility . Currency headwinds also pose a risk, particularly given the uneven geographic performance across different regions . Canada, for instance, is lagging behind other regions, which may impact overall growth .

Furthermore, the integration of MyMedic is still ongoing, with plans to expand distribution beyond direct-to-consumer channels into mass retail . While this expansion offers growth potential, it also introduces execution risks and increased competition. Investors should monitor these developments closely as they could significantly impact future revenue streams and market share .

Looking ahead, Acme United anticipates strong fourth-quarter profitability driven by seasonal demand . The company remains focused on integrating MyMedic and expanding its retail presence, which could drive further growth . However, the aforementioned risks, including elevated SG&A expenses and potential macroeconomic headwinds, will need to be managed carefully . The consistent dividend growth trajectory, with quarterly payouts increasing from $0.13 in 2021 to $0.16 in 2026, also reflects management's confidence in future cash flows . This commitment to shareholder returns, supported by consistent operational performance, reinforces the reliability of the income stream for long-term holders .